Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart Failure
- Resource Type
- Journal
- Source
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS ; JUL 25 2020, 13p.- Subject
- Language
- English
- ISSN
- 1179187X